PRESCIENT THERAPEUTICS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.041 AUD | -4.65% |
|
-10.87% | -33.87% |
| 03-25 | Transcript : Prescient Therapeutics Limited - Special Call | |
| 02-23 | Prescient Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Chart calendar Prescient Therapeutics Limited
dc545b8b82d6df973b69b.FCmuXcMCtdHqvR-5wGzJTcYmlXiLnXBhNgO9NW1oDhE.c1PAMKxggeaSynzXjRShGYFr30r6sBdTAFPeR1o5YCV2fsgCl2nil9jTVg~d3f96c21e085bb64ceea312d2d0692be
Upcoming events on Prescient Therapeutics Limited
Past events on Prescient Therapeutics Limited
| 2024-04-10 | Cutaneous Lymphomas World Congress |
| 2024-02-22 18:14 | Q2 2024 Earnings Release |
| 2024-01-30 19:52 | December 2023 Sales and Revenue Release - Activities Report |
| 2023-12-08 | American Society of Hematology Meeting |
| 2023-11-15 20:00 | Annual General Meeting |
| 2023-10-30 18:38 | September 2023 Sales and Revenue Release - Activities Report |
| 2023-10-09 | Cell & Gene Meeting on the Mesa Conference |
| 2023-08-24 19:07 | Q4 2023 Earnings Release |
| 2023-08-22 | Reach Markets The Insider Meet the CEO Conference |
| 2023-08-03 00:00 | TechKnow Invest Conference |
| 2023-07-26 19:07 | June 2023 Sales and Revenue Release - Activities Report |
| 2023-02-23 21:38 | Q2 2023 Earnings Release |
| 2023-02-09 | Investor Meeting |
| 2023-02-08 20:00 | Investor Meeting |
| 2023-01-24 21:45 | December 2022 Sales and Revenue Release - Activities Report |
| 2022-11-28 | Annual General Meeting |
| 2022-10-03 21:00 | Investor Meeting |
| 2022-09-29 | Investor Meeting |
| 2022-09-26 22:00 | Investor Meeting |
| 2022-09-20 22:00 | Investor Meeting |
Annual results
| Fiscal Period | June | 2019 | 2020 |
|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 1,72 0,00 - | 1,15 |
|
EBITDA Million AUD | Released Forecast Spread | -3,82 -4,90 22.03% | -4,49 |
|
EBIT Million AUD | Released Forecast Spread | -3,82 -4,90 22% | -4,49 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -3,80 -3,50 -8.49% | -3,32 |
|
Net income Million AUD | Released Forecast Spread | -3,80 -3,50 -8.49% | -3,32 |
|
EPS AUD | Released Forecast Spread | -0,02 -0,01 -55% | -0,01 |
| Announcement Date | 25/08/19 | 25/08/20 |
Quarterly results
| Fiscal Period | June | 2020 S1 | 2020 S2 |
|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 0,00 0,00 - | 0,51 |
|
EBITDA Million AUD | Released Forecast Spread | -2,23 -3,70 39.82% | -2,16 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -1,70 -2,30 26.21% | -1,62 |
|
Net income Million AUD | Released Forecast Spread | -1,70 -2,30 26.21% | -1,62 |
|
EPS AUD | Released Forecast Spread | 0,00 -0,01 57% | 0,00 |
| Announcement Date | 27/02/20 | 25/08/20 |
More events
Past sector events for Prescient Therapeutics Limited
| 2024-05-10 07:00 | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 2024-05-09 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 16:10 | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | HILLEVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | OMNIAB, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- PTX Stock
- Calendar Prescient Therapeutics Limited
